Knight Therapeutics announces Health Canada has approved Nerlynx for early-stage breast cancer

16 July 2019 - Knight Therapeutics announced today that Health Canada has approved Nerlynx (neratinib) for the extended adjuvant treatment of ...

Read more →

National regulator denied offer to give Canadian physicians training on abortion pill

16 July 2019 - The group representing Canada’s family doctors turned down an offer from a national abortion group to ...

Read more →

Esperoct is now approved in Canada for the treatment of haemophilia A in both children and adults

12 July 2019 - New treatment can help Canadians living with haemophilia A better manage their bleeding episodes ...

Read more →

Health Canada has authorised Vyvanse (lisdexamphetamine dimesylate), the first and only, chewable tablet for the treatment of attention deficit/hyperactivity disorder

10 July 2019 - Vyvanse offers an additional option for patients who prefer the convenience of a chewable tablet, or who ...

Read more →

Health Canada approves Pomalyst-based triplet combination for patients with multiple myeloma

10 July 2019 - Pomalyst in combination with bortezomib and dexamethasone, provides a new medication option for patients living with multiple ...

Read more →

Knight announces filing of new drug submission for Ibsrela in Canada

26 June 2019 - Knight Therapeutics announced today that Knight's new drug submission for Ibsrela (tenapanor) has been accepted for ...

Read more →

Health Canada approves Hemlibra for haemophilia A patients without factor VIII inhibitors

18 June 2019 - Hemlibra is the only treatment that can be self-injected subcutaneously once weekly for patients with hemophilia A ...

Read more →

Drug shortages in Canada: why they happen and what you can do about it

12 June 2019 - It’s not entirely unusual for Canadians see warnings emerge over drug shortages in the country. ...

Read more →

Sask. Cancer Agency started chemotherapy drug trial without required Health Canada approval

11 June 2019 - Agency says it 'proactively' paused trial 5 months after it started. ...

Read more →

Duchesnay is seeking Health Canada's approval for ospemifene for the treatment of moderate to severe dyspareunia and vaginal dryness, symptoms of vulvar and vaginal atrophy, a component of genitourinary syndrome of menopause

10 June 2019 - Duchesnay has filed a new drug submission with Health Canada for a once-daily oral ospemifene tablet, ...

Read more →

Health Canada approves Tecentriq (atezolizumab) combination therapy for first-line treatment of metastatic non-squamous non-small cell lung cancer

29 May 2019 - Data show this new option can help some patients with metastatic non-small cell lung cancer live significantly ...

Read more →

Janssen announces Health Canada approval of Tremfya One-Press (guselkumab) - a patient-controlled injector for adults with moderate-to-severe plaque psoriasis

29 May 2019 - The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that Health Canada has approved Tremfya One-Press, ...

Read more →

B.C. eye doctors warn province of spike in glaucoma cases linked to injections of eye drug

23 May 2019 - Thousands of retinal-disease patients in British Columbia are being exposed to an “increased risk of severe ...

Read more →

Health Canada approves Mylan and Biocon's Ogivri, the first trastuzumab biosimilar, for the treatment of HER2-positive breast and gastric cancers

22 May 2019 - Ogivri is a part of Mylan's robust portfolio of 20 biosimilar and insulin analog products. ...

Read more →

New made-in-Canada technique could revolutionise vaccine transportation

21 May 2019 - Researchers in Ontario have developed a new method of transporting life-saving vaccines to remote and impoverished ...

Read more →